Finance

Lists
IMTX:NASDAQ
Immatics NV
$7.06
-1.94%
(-0.14) 1D
$7.06
0.00% (0.00)
After hours
Closed: Nov 2, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IMTX...
Open
$7.24
High
$7.35
Low
$7.00
Mkt. cap
1.07B
Avg. vol.
1.09M
Volume
1.02M
52-wk high
$12.41
52-wk low
$6.65
EPS
-$1.77
Beta
1.36
Shares outstanding
149.64M
No. of employees
704
Open
$7.24
High
$7.35
Low
$7.00
Mkt. cap
1.07B
Avg. vol.
1.09M
Volume
1.02M
52-wk high
$12.41
52-wk low
$6.65
EPS
-$1.77
Beta
1.36
Shares outstanding
149.64M
No. of employees
704
News stories
From web sources and news partners
About Immatics NV
CEOHarpreet Singh
Employees704
Founded2000
Headquarters-
SectorBiotechnology
Websiteimmatics.com
Analyst ratings
Based on 6 analysts giving stock ratings to IMTX in the past 3 months
Strong buy
Buy
6
Hold
0
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for IMTX in the last 3 months.
Highest
Current $7.06
$21.00 (+197.45%)
Average
$16.36 (+131.73%)
Lowest
$11.80 (+67.14%)
Analyst
Recommendation
Action
Price target
Projected
Date
Graig Suvannavejh
Mizuho Securities
Buy
Maintained
$21.00
+197.5%
10/29/2026
Laura Prendergast
Stifel Nicolaus
Buy
Maintained
$15.00
+112.5%
10/26/2026
Alec Stranahan
Bank of America Securities
Buy
Maintained
$17.00
+140.8%
10/26/2026
Faisal Khurshid
Jefferies
Buy
Reiterated
$17.00
+140.8%
08/25/2026
Nicholas Lorusso
TD Cowen
Buy
Maintained
-
-
08/18/2026
Rajan Sharma
Goldman Sachs
Buy
Maintained
$11.80
+67.1%
08/18/2026
Geulah Livshits
Chardan Capital
Buy
Reiterated
$25.00
+254.1%
05/19/2026
Paul Jeng
Guggenheim
Buy
Maintained
$19.00
+169.1%
05/12/2026
Unknown Analyst
Goldman Sachs
Buy
Maintained
$12.20
+72.8%
05/13/2026
Jonathan Chang
Leerink Partners
Buy
Reiterated
$17.00
+140.8%
03/06/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in EUR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
5.19M
19.76M
7.61M
9.14M
Cost of goods sold
47.18M
49.64M
59.19M
62.41M
Cost of revenue
47.18M
49.64M
59.19M
62.41M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
12.67M
13.66M
14.51M
13.94M
Operating expense
12.64M
9.00M
14.49M
13.94M
Total operating expenses
59.82M
58.64M
73.68M
76.35M
Operating income
-54.63M
-38.88M
-66.06M
-67.20M
Other non operating income
77.00K
15.00K
-30.00K
54.00K
EBT including unusual items
-50.67M
-35.56M
-57.76M
-62.77M
EBT excluding unusual items
-50.67M
-35.56M
-57.76M
-62.77M
Income tax expense
-127.00K
134.00K
52.00K
-274.00K
Effective tax rate
0.25%
-0.38%
-0.09%
0.44%
Other operating expenses
-29.00K
-4.66M
-24.00K
-
Net income
-50.54M
-35.70M
-57.81M
-62.49M
Net profit margin
-974.46%
-180.65%
-759.51%
-683.42%
Earnings per share
-
-
-
-
Interest and investment income
3.91M
3.55M
3.58M
3.29M
Interest expense
-231.00K
-222.00K
-212.00K
-203.00K
Net interest expenses
3.68M
3.33M
3.37M
3.08M
Depreciation and amortization charges
-
-
-
-
EBITDA
-51.57M
-36.60M
-63.29M
-64.20M
Gain or loss from assets sale
117.00K
593.00K
48.00K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps